We observed that ECs with the enhancer deletion exhibited impaired wound healing, as did ECs with knock-outs of either MYO9B or HAUS8, suggesting that the regulatory effect of the enhancer contributes to CAD risk through impaired wound healing in ECs (Fig. 6f). Here, MYO9B is linked to coronary artery disorder.